We are live on !
Find out more
AI
Axecap Investments Portfolio holdings
AUM
$181M
Turnover
42.22%
1-Year Est. Return
75.22%
This Fund
S&P 500
This Quarter Est. Return
+44.62%
1 Year Est. Return
+75.22%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$181M
AUM Growth
+$35.5M
(+24%)
Cap. Flow
-$2.14M
Cap. Flow % of AUM
Cap. Flow %
-1.19%
Top 10 Holdings %
Top 10 Hldgs %
34.85%
Holding
90
New
21
Increased
15
Reduced
29
Closed
17
Avg Time Held
0.7
years
Top 10 Avg Time Held
0.2
years
Top 20 Avg Time Held
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$5.19M |
| 2 |
CrowdStrike
CRWD
|
+$4.79M |
| 3 |
Palo Alto Networks
PANW
|
+$4.7M |
| 4 |
Tapestry
TPR
|
+$4.59M |
| 5 |
Targa Resources
TRGP
|
+$4.39M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$5.02M |
| 2 |
KLA
KLAC
|
+$4.72M |
| 3 |
Valero Energy
VLO
|
+$4.34M |
| 4 |
RTX Corp
RTX
|
+$4.16M |
| 5 |
JPMorgan Chase
JPM
|
+$3.88M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 53.7% |
| 2 | Financials | 12.07% |
| 3 | Consumer Discretionary | 9.3% |
| 4 | Healthcare | 6.78% |
| 5 | Energy | 6.53% |
Similar funds
AMAL
SWM
RWS
MIM
ACM
GSP
DF
NWM
Axecap Investments's Q2 2026 Portfolio in Review
As of Q2 2026, Axecap Investments held 90 positions worth $181M, up 24% from $145M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Axecap Investments's Q2 2026 filing shows 21 new, 15 increased, 29 reduced and 17 closed positions. Its largest new stake was UnitedHealth: 13,996 shares worth $5.82M. The largest sale was Lam Research, an estimated $5.02M.
By sector, the portfolio is most concentrated in Technology at 54% of assets, up from 36% a quarter earlier, followed by Financials and Consumer Discretionary.
- Axecap Investments's largest Q2 2026 buy was UnitedHealth: 13,996 shares worth $5.82M.
- Axecap Investments added most to Marathon Petroleum in Q2 2026, an estimated $4.27M increase.
- Axecap Investments's biggest Q2 2026 reduction was Lam Research, cutting an estimated $5.02M.
- Axecap Investments fully exited Phibro Animal Health in Q2 2026, selling an estimated $3.85M.
- Axecap Investments's ten largest holdings make up 35% of its $181M portfolio in Q2 2026.
- Axecap Investments opened 21 new positions and closed 17 in Q2 2026.
- Axecap Investments's portfolio value rose 24% quarter-over-quarter to $181M.
Based on Axecap Investments's 13F filing for Q2 2026, filed 10 Aug 2026.